|
MechanismSARS-CoV-2 antigen inhibitors |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Dollvet Veterinary Vaccine Pharmaceutical Biological Substance Production Industry Co., Ltd.
0 Patents (Medical) associated with Dollvet Veterinary Vaccine Pharmaceutical Biological Substance Production Industry Co., Ltd.
100 Deals associated with Dollvet Veterinary Vaccine Pharmaceutical Biological Substance Production Industry Co., Ltd.
100 Translational Medicine associated with Dollvet Veterinary Vaccine Pharmaceutical Biological Substance Production Industry Co., Ltd.